PLIBX
Price
$37.08
Change
+$0.12 (+0.32%)
Updated
Jan 17 closing price
Net Assets
65.46M
RLBBX
Price
$34.70
Change
+$0.21 (+0.61%)
Updated
Jan 17 closing price
Net Assets
240.18B
Ad is loading...

PLIBX vs RLBBX

Header iconPLIBX vs RLBBX Comparison
Open Charts PLIBX vs RLBBXBanner chart's image
Plumb Balanced Institutional
Price$37.08
Change+$0.12 (+0.32%)
VolumeN/A
Net Assets65.46M
American Funds American Balanced R2
Price$34.70
Change+$0.21 (+0.61%)
VolumeN/A
Net Assets240.18B
PLIBX vs RLBBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PLIBX vs. RLBBX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLIBX is a Buy and RLBBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 240B vs. PLIBX (65.5M). RLBBX pays higher dividends than PLIBX: RLBBX (1.58) vs PLIBX (1.24). PLIBX was incepted earlier than RLBBX: PLIBX (4 years) vs RLBBX (23 years). RLBBX is a more actively managed with annual turnover of: 171.00 vs. PLIBX (36.00). RLBBX has a lower initial minimum investment than PLIBX: RLBBX (250) vs PLIBX (2500). PLIBX annual gain was more profitable for investors over the last year : 14.85 vs. RLBBX (11.43).
PLIBXRLBBXPLIBX / RLBBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence4 years23 years-
Gain YTD1.4221.90975%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets65.5M240B0%
Annual Yield % from dividends1.241.5878%
Returns for 1 year14.8511.43130%
Returns for 3 years9.3210.5489%
Returns for 5 yearsN/A25.81-
Returns for 10 yearsN/A49.88-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUN17.870.46
+2.64%
Huntsman Corp
PUBM14.520.11
+0.76%
PubMatic
SATL2.900.02
+0.69%
Satellogic
ACGL95.51-0.59
-0.61%
Arch Capital Group Ltd
LEXX1.90-0.08
-3.80%
Lexaria Bioscience Corp